Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): An open-label randomised study
- Pivot, X.
- Gligorov, J.
- Müller, V.
- Barrett-Lee, P.
- Verma, S.
- Knoop, A.
- Curigliano, G.
- Semiglazov, V.
- López-Vivanco, G.
- Jenkins, V.
- Scotto, N.
- Osborne, S.
- Fallowfield, L.
ISSN: 1470-2045, 1474-5488
Année de publication: 2013
Volumen: 14
Número: 10
Pages: 962-970
Type: Article